Dacy Reimer
Adult Health · Milwaukee, WINPI 1144656851
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,397 of the $3,470 with a category attached, or 69.1%. Amneal Pharmaceuticals LLC accounts for 82.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $1,520 and has fallen 92.7% since, to $112 in 2024. Among adult health clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 58 payments — averaging $59.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amneal Pharmaceuticals LLC$3K
- Biogen$141
- Biohaven Pharmaceuticals, Inc.$87
- Kyowa Kirin, Inc.$69
- Novartis$64
- Corium, LLC$50
- plus $188 from 9 others
What the payments were for
- Consulting fees$251%
- Speaking & faculty fees$2,39769%
- Food & beverage$1,04730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amneal Pharmaceuticals LLC | 34 | $2,871 |
| Biogen | 4 | $141 |
| Biohaven Pharmaceuticals, Inc. | 3 | $87 |
| Kyowa Kirin, Inc. | 3 | $69 |
| Novartis | 3 | $64 |
| Corium, LLC | 2 | $50 |
| Abbott | 1 | $48 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| UCB, Inc. | 1 | $22 |
| EMD Serono, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Pfizer | 1 | $16 |
| Boston Scientific | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYTARY$2,397
How this compares
$3,470 in reported general payments places this provider in the 90th percentile of 170 adult health providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 186 | $182,333 |
| NuplazidPimavanserin Tartrate | 22 | $82,626 |
| NourianzIstradefylline | 19 | $39,632 |
| OngentysOpicapone | 32 | $31,222 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 795 | $30,800 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 401 | $30,741 |
| RexultiBrexpiprazole | 21 | $19,795 |
| NeuproRotigotine | 21 | $19,604 |
| Memantine Hcl | 706 | $14,978 |
| AmantadineAmantadine Hcl | 152 | $10,752 |
| Rivastigmine | 41 | $8,812 |
| Ropinirole ErRopinirole Hcl | 34 | $6,425 |
| AdlarityDonepezil Hcl | 12 | $5,713 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 132 | $5,219 |
| Selegiline Hcl | 27 | $4,662 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCRytary | $2,871 | $182,333186 claims |
| Kyowa Kirin, Inc.Nourianz | $69 | $39,63219 claims |
| Neurocrine Biosciences, Inc.Ongentys | $14 | $31,22232 claims |
| UCB, Inc.Neupro | $22 | $19,60421 claims |
| Corium, LLCAdlarity | $50 | $5,71312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 170 adult health providers in Wisconsin.
Other adult health in Milwaukee
- Winsome PantonMilwaukee$46K
- Anatoliy VelikodanovMilwaukee$10K
- Annike CollinsMilwaukee$9K
- Nicole RosinMilwaukee$4K
- Kaylan FentonMilwaukee$4K
- Ildiko DomanicoMilwaukee$3K
- Claire DohmenMilwaukee$3K
- Laura LuMilwaukee$3K
- Jessica KurowskiMilwaukee$2K
- Ruth TreismanMilwaukee$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.